IL-21R Signaling is Critical for Induction of Spontaneous Experimental Autoimmune Encephalomyelitis
Overview
Affiliations
IL-17-producing CD4+ T cells (Th17 cells) have well-described pathogenic roles in tissue inflammation and autoimmune diseases, such as experimental autoimmune encephalomyelitis (EAE); however, the involvement of IL-21 in these processes has remained controversial. While IL-21 is an essential autocrine amplification factor for differentiation of Th17 cells, the loss of IL-21 or IL-21 receptor (IL-21R) does not protect mice from actively induced EAE. Here, we utilized a transgenic EAE mouse model, in which T and B cells overexpress receptors for myelin oligodendrocyte glycoprotein (MOG) (referred to as 2D2xTH mice), and demonstrated that IL-21 is critical for the development of a variant form of spontaneous EAE in these animals. Il21r deletion in 2D2xTH mice reduced the incidence and severity of spontaneous EAE, which was associated with a defect in Th17 cell generation. Moreover, IL-21R deficiency limited IL-23R expression on Th17 cells and inhibited expression of key molecules involved in the generation of pathogenic Th17 cells. Conversely, loss of IL-23R in 2D2xTH mice resulted in complete resistance to the development of spontaneous EAE. Our data identify a previously unappreciated role for IL-21 in EAE and reveal that IL-21-mediated signaling supports generation and stabilization of pathogenic Th17 cells and development of spontaneous autoimmunity.
Myelin-reactive B cells exacerbate CD4 T cell-driven CNS autoimmunity in an IL-23-dependent manner.
Fazazi M, Doss P, Pereira R, Fudge N, Regmi A, Joly-Beauparlant C Nat Commun. 2024; 15(1):5404.
PMID: 38926356 PMC: 11208426. DOI: 10.1038/s41467-024-49259-0.
Tertiary lymphoid structures in autoimmune diseases.
Dong Y, Wang T, Wu H Front Immunol. 2024; 14:1322035.
PMID: 38259436 PMC: 10800951. DOI: 10.3389/fimmu.2023.1322035.
Wu H, Fu Q, Teng Y, Mu P, Chen J, Chen X Mol Biol Rep. 2023; 50(12):10121-10129.
PMID: 37921979 DOI: 10.1007/s11033-023-08827-1.
Pham H, Pham L, Sato K PLoS One. 2023; 18(10):e0292998.
PMID: 37844121 PMC: 10578581. DOI: 10.1371/journal.pone.0292998.
Duan J, Matute J, Unger L, Hanley T, Schnell A, Lin X Immunity. 2023; 56(5):1115-1131.e9.
PMID: 36917985 PMC: 10175221. DOI: 10.1016/j.immuni.2023.02.018.